Regulatory network analysis defines unique drug mechanisms of action and facilitates patient-drug matching in alopecia areata clinical trials

by James C. Chen, Zhenpeng Dai, Angela M. Christiano
Published 2021-01-01

Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata

by Zhenpeng Dai, James Chen, Yuqian Chang, Angela M. Christiano
Published 2021-04-01

Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells.

by Xin Cai, Zhenpeng Dai, Rebecca S Reeves, Andrea Caballero-Benitez, Kate L Duran, Jeffrey J Delrow, Peggy L Porter, Thomas Spies, Veronika Groh
Published 2014-01-01

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

by Ali Jabbari, Zhenpeng Dai, Luzhou Xing, Jane E. Cerise, Yuval Ramot, Yackov Berkun, Gina A. Montealegre Sanchez, Raphaela Goldbach-Mansky, Angela M. Christiano, Raphael Clynes, Abraham Zlotogorski
Published 2015-04-01